Johnson & Johnson is a global healthcare company focused on Innovative Medicine and MedTech after separating its consumer-health business into Kenvue. In FY2025, Johnson & Johnson reported sales to customers of $94.193 billion and net earnings of $26.804 billion. The company reported approximately 140,800 employees and is led by Chairman and CEO Joaquin Duato.
Johnson & Johnson: Key Facts
- Founded in 1886 in New Brunswick, New Jersey.
- Reported FY2025 sales to customers of $94.193 billion.
- Reported FY2025 net earnings of $26.804 billion.
- Had approximately 140,800 employees as of December 28, 2025.
- Operates Innovative Medicine and MedTech segments.
- Led by Chairman and CEO Joaquin Duato.
How Johnson & Johnson Makes Money
Innovative Medicine is the largest segment, generating $60.401 billion in FY2025 sales from oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism medicines. MedTech generated $33.792 billion from surgery, orthopaedics, cardiovascular, and vision products.
Why Johnson & Johnson Matters
J&J matters because it combines global clinical development, commercial reach, regulatory capability, and MedTech manufacturing at rare scale. After Kenvue, investors judge the company more directly on medicine and medical-device performance.
Competitive Position
Johnson & Johnson competes with Pfizer, Merck, AbbVie, Eli Lilly, and major MedTech companies. Its opportunity is growth in oncology, immunology, neuroscience, cardiovascular MedTech, and surgery. Its risk is patent loss, pricing pressure, litigation, and R&D execution.
